EUVIMEDEUVIMED entdecken
Open Access

National Cancer Institute funding for rapid cycle interventional research in cancer care delivery

Wynne E Norton iD, Gila Neta, Paul B Jacobsen

JNCI Cancer Spectrum · 31.10.2023 · 7 (6)

DOI: 10.1093/jncics/pkad089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 20.10.2023. Verfasst von Wynne E Norton und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA. Hauptthemen laut MEDLINE: Biomedical Research, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rapid cycle interventional research can accelerate improvements to cancer care delivery and patient health outcomes by answering multiple questions as part of a single research study. To complement ongoing efforts to increase awareness of and support for rapid cycle interventional research, we conducted a systematic portfolio analysis of research grants funded by the National Cancer Institute on the topic.

Methods

We used standard portfolio analytic methods for identifying, coding, and synthesizing rapid cycle interventional research funded by the National Cancer Institute between 2016 and 2022. A codebook was used to standardize assessment of the grants by common study characteristics, intervention topics, and cancer care delivery context.

Results

We identified 26 grants, mostly funded since 2019, as rapid cycle interventional research. Most studies included adult or older adult target populations, used electronic systems for intervention delivery, and focused primarily on testing different components of interventions. Studies also used a range of study designs, intervention content areas, cancer sites, and across the cancer control continuum.

Conclusions

The current portfolio analysis of funded rapid cycle interventional research grants suggests a growing albeit relatively small number of studies in this area. Several efforts are needed to continue to grow this area of research, including training programs, funding opportunities, and strengthening research-practice partnerships. This analysis provides a snapshot of current studies and highlights the opportunity for growing this important area of research to optimize cancer care delivery and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomedical ResearchNeoplasmsUnited StatesHumansAgedNational Cancer Institute (U.S.)Financing, OrganizedResearch Personnel

Autor:innen und Institutionen

  • Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.

ORCID-Profile: Wynne E Norton

Zitieren

APA

Norton, W. E., Neta, G., & Jacobsen, P. B. (2023). National Cancer Institute funding for rapid cycle interventional research in cancer care delivery. JNCI Cancer Spectrum, 7(6). https://doi.org/10.1093/jncics/pkad089

Vancouver

Norton WE, Neta G, Jacobsen PB. National Cancer Institute funding for rapid cycle interventional research in cancer care delivery. JNCI Cancer Spectrum. 2023;7(6). doi:10.1093/jncics/pkad089

BibTeX
@article{Norton2023,
  author = {Norton, Wynne E and Neta, Gila and Jacobsen, Paul B},
  title = {National Cancer Institute funding for rapid cycle interventional research in cancer care delivery},
  journal = {JNCI Cancer Spectrum},
  year = {2023},
  volume = {7},
  number = {6},
  doi = {10.1093/jncics/pkad089}
}
Kostenlos starten →